News & Events
BILLERICA, Mass. and MUNICH, Germany, Mar. 5, 2025. Momentum Biotechnologies ("Momentum"), a contract research organization ("CRO") specializing in mass spectrometry-based drug dis...
We will present our chemical proteomics solutions at the Emergence of irreversible modulation in drug discovery meeting of the British Pharmacological Society in Cambridge, UK. Rea...
We are proud to present another one of our latest additions to our service and assay portfolio:
We developed the NucleoBeads platform to capture native DNA binding proteins and th...
Additionally, we are proud to unveil our latest achievement - the comprehensive Protein Turnover Atlas ????. Covering over 14,000 human proteins across 30+ diverse cell lines and t...
We will present our chemical proteomics solutions at the Inaugural Covalent Drug Discovery Summit in Boston. Feel free to reach out to us in advance, if you would like to learn, ho...
We are pleased to support the EFMC-ISCB symposium on chemical biology in Basel next week (16.-18.11.2023) as a premium exhibition partner, and are looking forward to meeting past, ...
We are proud to present one of the latest additions to our service and assay portfolio: SideScout™ enables tracking drug action in living cells in a label-free manner. The technolo...
All actions of a drug can be understood better by understanding its direct interactions with proteins and the downstream effects of such interactions.
With DecryptM we have develo...
We are thrilled to congratulate the team around Bernard Haendler and Ekaterina Nevedomskaya on their recent publication of a multi-omics study on the proximal changes of androgen-s...
We are going to attend the Neuroscience2022 conference organized by the Society for Neuroscience. It will take place November 12-16 at San Diego Convention Center.Meet us there or ...
Meet us at BioEurope 2022 in Leipzig, October 24-26
Andreas Köpke will be representing us and can be found at the BioM Biotech joint booth #112.Try your luck or schedule a meeting...
We are looking for a Computational Biologist or Bioinformatician to join our team.
Find details here:
Bioinformatician (m/w/d) - 40 h per week, permanent position
We congratulate our co-founders and scientific advisors Bernhard Kuster and Mathias Wilhelm, their colleagues and collaborators for their recent publication on the draft of the mur...
In this large collaborative study with partners from DKFZ, Bayer and others, OmicScouts proteomic technologies helped to identify the target and mechanism of NCT02, a compound that...
Proteins are the most important biochemical function carriers. Their totality is called the proteome. Since the proteome of a cell or an organism is strongly influenced by external...
To strengthen our multidisciplinary team, we are looking for
Research Associate Biochemistry and Mass Spectrometry (MS)-based Proteomics
Computational Biologist or Bioinformati...
Together with our partners at the TUM Chair of Proteomics and Bioanalytics and the TUM Institute of Virology, we received grant funding of the Bayrische Forschungsstiftung for a pr...
Together with the Medical University of Vienna, TAmiRNA GmbH, and other partners, OmicScouts published a study on the combined used of proteomics and miRNomics as screening tools f...
OmicScouts will attend the premier partnering conference BIO-Europe. Take the opportunity and meet us in Hamburg between 11th and 13th November 2019. Meet our experts to discuss yo...
We are expanding our technology portfolio: We now support our drug discovery clients working in the field of event-driven pharmacology with our TurnoverScout™ technology.
As more ...